Psychiatry may soon have its first set of objective clinical laboratory blood tests for mood disorders. Researchers at the Indiana University School of Medicine recently published their findings in Molecular Psychiatry. Working with 11 different genes, they described a “predictive score [that was] developed based on a panel of 10 top candidate biomarkers (five for high mood and five for low mood) [that] shows sensitivity and specificity for high mood and low mood states, in two independent cohorts.”
MORE ON: Mood Disorders
These research findings show how new genetic technologies will soon provide psychiatry with more precise diagnostic tests. As this occurs, psychiatrists are likely to become significant sources of laboratory test referrals for the nation’s clinical laboratories.
- Jerry R. Goldsmith is retiring from the American Association of Clinical Chemistry (AACC) after 15 years of service. April 4 was his last official day at AACC, but he will continue to serve the association as a consultant. He has founded Sandpiper Strategies as his new enterprise. Goldsmith’s energetic work on behalf of AACC and the entire lab industry has been widely recognized.
- Joe Perrone, Sc.D., joined AACC as its new Vice President of Strategic Initiatives and Business Development. He will assume many of Jerry Goldsmith’s former responsibilities. Perrone was most recently at the American Type Culture Collection. He earlier worked with the University of Maryland Biotechnology Institute and Becton Dickinson.
- Luminex Corporation of Austin, Texas, recently named Randel S. Marfin to the new position of Vice President of Strategic Development. Marfin, who joined Luminex during its formation 11 years ago, has served in executive positions with MetPath, Nichols Institute, and Damon Clinical Laboratories. Luminex also announced that Gregory J. Gosch will be Vice President of the Luminex Bioscience Group while Darin Leigh will serve as Vice President of Sales and Marketing.
- Laboratory Alliance of Central New York, LLC, named Michael R. O’Leary, M.D., as its new Chief Executive Officer. Since the lab organization’s founding in 1998, O’Leary has been Corporate Medical Director. O’Leary also serves on the Pathology Advisory Council of The Joint Commission.
Dark Daily Update
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about…
…a new product that allows individuals to keep preserved DNA “shrink-wrapped” at room temperature. It’s new technology for consumers interested in keeping DNA for medical and non-medical uses. You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.